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a b s t r a c t
Neural crest cells (NCCs) are physically responsible for craniofacial skeleton formation, pharyngeal arch
artery remodeling and cardiac outﬂow tract septation during vertebrate development. Cdc42 (cell
division cycle 42) is a Rho family small GTP-binding protein that works as a molecular switch to regulate
cytoskeleton remodeling and the establishment of cell polarity. To investigate the role of Cdc42 in NCCs
during embryonic development, we deleted Cdc42 in NCCs by crossing Cdc42 ﬂox mice with Wnt1-cre
mice. We found that the inactivation of Cdc42 in NCCs caused embryonic lethality with craniofacial
deformities and cardiovascular developmental defects. Speciﬁcally, Cdc42 NCC knockout embryos
showed fully penetrant cleft lips and short snouts. Alcian Blue and Alizarin Red staining of the cranium
exhibited an unfused nasal capsule and palatine in the mutant embryos. India ink intracardiac injection
analysis displayed a spectrum of cardiovascular developmental defects, including persistent truncus
arteriosus, hypomorphic pulmonary arteries, interrupted aortic arches, and right-sided aortic arches.
To explore the underlying mechanisms of Cdc42 in the formation of the great blood vessels, we
generated Wnt1Cre-Cdc42-Rosa26 reporter mice. By beta-galactosidase staining, a subpopulation of
Cdc42-null NCCs was observed halting in their migration midway from the pharyngeal arches to the
conotruncal cushions. Phalloidin staining revealed dispersed, shorter and disoriented stress ﬁbers in
Cdc42-null NCCs. Finally, we demonstrated that the inactivation of Cdc42 in NCCs impaired bone
morphogenetic protein 2 (BMP2)-induced NCC cytoskeleton remodeling and migration. In summary, our
results demonstrate that Cdc42 plays an essential role in NCC migration, and inactivation of Cdc42 in
NCCs impairs craniofacial and cardiovascular development in mice.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Craniofacial and cardiovascular malformations comprise more than
one-third of human congenital diseases (Hoffman and Kaplan, 2002;
Walker and Trainor, 2006). The formation of craniofacial and cardio-
vascular structures is an orchestrated process and largely depends on
the speciﬁc interactions between neural crest cells (NCCs) and their
surrounding cells, which are derived from the ectoderm, endoderm
and splanchnic mesoderm (Hutson and Kirby, 2007; Sauka-Spengler
and Bronner-Fraser, 2008; Stoller and Epstein, 2005). NCCs are a
multipotent cell population that originate from the border between
the neural tube and surface ectoderm. After induction, NCCs undergo
epithelial-to-mesenchymal transition, migrate stereotypically to
diverse locations and then differentiate into multiple cell types at their
destinations (Knecht and Bronner-Fraser, 2002; Trainor, 2005), includ-
ing craniofacial skeletons, as well as vasculature and smooth muscle
cells in the conotruncal structures of the heart (Chai and Maxson,
2006; Hutson and Kirby, 2007). Cardiac NCCs, a subpopulation of
cranial NCCs that emigrate from the region between the otic placode
and the caudal border of somite three, are necessary for
proper septation of the cardiac outﬂow tract and correct alignment
of aortic arch arteries (Hutson and Kirby, 2007; Stoller and Epstein,
2005). During embryogenesis, cardiac NCCs ventrolaterally migrate
into pharyngeal arch three, four, and six, and a subpopulation of cells
continue migrating to cardiac outﬂow tract cushions. Experiments on
both chicken and mouse embryos have shown that cardiac NCCs are
essential for outﬂow tract septation (Kirby, 1987; Porras and Brown,
2008; Waldo et al., 1998). Interference of NCC functions results in
persistent truncus arteriosus (PTA) and a shortened outﬂow tract
(Goddeeris et al., 2007; Snider et al., 2007) that causes malalignment
of the outﬂow tract and cardiac loop defects (Watanabe et al., 2010;
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Yelbuz et al., 2002). The molecular signals that operate in NCCs during
craniofacial and cardiovascular formation remain to be addressed.
GTP-binding (G) proteins act as molecular switches that regulate a
vast array of cellular activities and biological responses (Bar-Sagi and
Hall, 2000; Hall, 1992; Neer, 1995). Cdc42 (cell division cycle 42)
together with Rac and RhoA are members of the Rho subfamily in the
Ras superfamily of GTPases (Johnson, 1999; Ridley, 1996; Symons,
1996; Van Aelst and D'Souza-Schorey, 1997). It is well documented
that Cdc42 plays a critical role in regulating cytoskeleton reorganiza-
tion, the formation of ﬁlopodia and focal adhesion complexes, the
establishment of microtubule-dependent cell polarity, gene tran-
scription, intracellular trafﬁcking, and endocytosis (Erickson and
Cerione, 2001; Etienne-Manneville, 2004; Etienne-Manneville and
Hall, 2002; Jaffe and Hall, 2005; Wu et al., 2000). Hence, Cdc42 is a
critical regulator of many cellular functions such as cell cycle
progression, migration, differentiation, and apoptosis (Cerione,
2004; Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005).
A potential role of Cdc42 in NCCs in craniofacial and cardiovascular
development has been suggested by a number of studies. Rho GEF
and PH domain-containing protein 1 (FGD1) is a Cdc42 putative
guanine nucleotide-exchange factor, and mutations in the human
FGD1 gene have been shown to cause faciogenital dysplasia (Pasteris
et al., 1994; Zheng et al., 1996). GTP-bound Cdc42 is able to interact
with and thereby activate downstream targets, the so-called effector
proteins. Over 20 target proteins for Cdc42 have been identiﬁed in
mammalian cells, including PAK, Cool-1 (cloned-out of library 1),
WASP (Wiskott–Aldrich syndrome protein) and IQGAP. PAK1 is one
of the ﬁrst Cdc42 effectors identiﬁed, and the overexpression of
dominant negative PAK1 inhibits NCC migration (Bisson et al., 2012).
In addition, Cdc42 is activated by integrins and focal adhesion kinase
(FAK) (Dormond et al., 2001; Etienne-Manneville and Hall, 2001;
Feng et al., 2006; Price et al., 1998), and loss of integrin β1 or FAK in
NCCs results in craniofacial and cardiovascular developmental defects
(Pietri et al., 2004; Vallejo-Illarramendi et al., 2009). Cdc42 is
involved in regulating growth factor-initiated signal transduction
pathways, including bone morphogenetic proteins (BMPs) (Gamell
et al., 2008), ﬁbroblast growth factors (FGFs) (Endo et al., 2009),
vascular endothelial growth factors (VEGFs) (Lamalice et al., 2004;
Zeng et al., 2002), and the critical functions of these growth factors in
NCCs are well accepted (Kulesa et al., 2010). All of this evidence
indicates that Cdc42 may be a critical regulator in NCCs during
craniofacial and cardiovascular development.
BMPs are transforming growth factor-β (TGF-β) superfamily
members and are among the ﬁrst factors identiﬁed in the regula-
tion of NCC development (Correia et al., 2007; Walsh et al., 2010).
The evidence generated from studying genetically modiﬁed mice
has demonstrated that BMP2 is one of the most important growth
factors in NCC migration. The deletion of BMP2 caused the absence
of migratory NCCs (Correia et al., 2007). Consistently, overexpres-
sion of Xnoggin, which is a BMP2 inhibitor, blocked NCC migration
(Kanzler et al., 2000). Moreover, NCC-speciﬁc deletion of BMP2
receptors, either ActRIA (ALK2) or BMPR1A (ALK3), brought about
defective formation of the cardiac outﬂow tract, including a
shortened outﬂow tract (Dudas et al., 2004; Kaartinen et al.,
2004; Stottmann et al., 2004). The importance of BMP2 in cell
migration was also documented in cultured C2C12 cells (a type of
mouse myoblast). Exposure of C2C12 cells to BMP2 enhanced actin
cytoskeleton reorganization and migration, and these effects were
abolished when Cdc42 function was inhibited (Gamell et al., 2008).
Consistent with its critical cellular functions, the total deletion
of Cdc42 caused embryonic lethality with aberrant actin cytoske-
leton organization (Chen et al., 2000). Using tissue-speciﬁc gene
knockout technology (Cre-LoxP system), Cdc42 has been impli-
cated to play a critical role in neuron apical progenitor cell renewal
and cerebral hemispheres separation (Cappello et al., 2006; Chen
et al., 2006; Peng et al., 2013). However, relatively little is known
about the functions of Cdc42 in craniofacial and cardiovascular
development. While a recent study has shown that Cdc42 is
important for NCC self-renewal and proliferation, the relatively
early embryonic lethality (embryonic day 13.5, E13.5) of these
Cdc42 NCC knockout mice made it impossible to conduct a
detailed analysis of craniofacial and aortic arch artery defects
because the knockout embryos died before these structures were
formed (Fuchs et al., 2009). To determine the role and molecular
mechanisms of Cdc42 in craniofacial and cardiovascular develop-
ment, we generated a NCC-speciﬁc Cdc42 knockout mouse line by
crossing Cdc42 ﬂox mice (Peng et al., 2013) with Wnt1-Cre mice
(Danielian et al., 1998). We found that the deletion of Cdc42 in
NCCs induced embryonic lethality with craniofacial morphoge-
netic defects. In addition, we observed that the inactivation of
Cdc42 in NCCs caused abnormal great vessel patterns and aortic
and pulmonary septation defects. Cellular function analysis
showed that Cdc42 is crucial for BMP2-induced cytoskeleton
remodeling and migration.
Materials and methods
Generation of NCC Cdc42-speciﬁc knockout mice
Cdc42/ﬂox mice (Peng et al., 2013) were crossed with Wnt1-cre
mice (Danielian et al., 1998) to inactivate Cdc42 in NCCs. The LacZ
enzyme gene was introduced into Cdc42 NCC knockout mice by
crossing Cdc42 and Wnt1-cre double heterozygous mice with R26R-
STOP-lacZ mice. The genotypes of embryos and pups obtained by
crossing Cdc42ﬂox/þ;creþ mice with Cdc42 ﬂox/ﬂox mice were
determined by PCR using forward (TGC CTC TAC CTC CTA AGT GC
TGG GA) and reverse primers (AGA GGA CCC TTA CAG GCC TCT TCC
A). Cycling conditions were as follows: 3 cycles at 94 1C for 3 min,
67 1C for 2 min and 72 1C for 1 min; 30 cycles at 94 1C for 1 min,
67 1C for 1 min and 72 1C for 1 min; 1 cycle at 72 1C for 10 min. The
expected sizes of wild-type allele and ﬂoxed alleles were 206 bp and
412 bp, respectively. Mice were housed in a pathogen-free facility
and handled in accordance with the principles of the Guide for the
Care and Use of Laboratory Animals. All protocols were approved by
the Institutional Animal Care and Use Committee (IACUC) of Texas
A&M Health Science Center.
Skeleton staining
E18.5 embryos were de-skinned, eviscerated and ﬁxed in 95%
ethanol for 2 days. The skeleton was then stained in Alcian blue
staining solution (0.03% Alcian Blue, 80% ethanol, 20% acetic acid)
for 3 days. After washing with 95% ethanol for 1 day, and 95%
ethanol with 2% KOH for 2 days at room temperature, Alizarin Red
solution (0.03% Alizarin Red, 1% KOH in water) was added and the
embryo stained for another 2 days. Finally the embryos were
cleared in 1% KOH/20% glycerol solution and stored in 1:1 glycerol/
95% ethanol for imaging.
Histological analysis and immunoﬂuorescence staining
Embryos were harvested at stages from E9.5 to E18.5 and ﬁxed
in 4% paraformaldehyde at 4 1C for overnight. Parafﬁn embedded
embryos were then sectioned and stained with H&E or eosin.
Immunoﬂuorescence staining was performed on cryosections, as
described previously (Peng et al., 2008), and information on the
antibodies follows: Phalloidin (p1951; Sigma; 1:100), Phospho-
histone H3 (06-570; Upstate Biotechnology; 1:100), Smooth Mus-
cle Actin (M0851; DAKO; 1:5000), SM22alpha (ab14106; Abcam;
1:100), Troponin T Ab-1 (MS295PO; Thermo Scientiﬁc; 1:100),
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SOX10 (MAB2864; R&D Systems; 1:100), and Cdc42 (07-1466;
Millipore; 1:500).
Whole-mount X-gal staining
Embryos were carefully dissected and rinsed in PBS and ﬁxed in
4% paraformaldehyde at 4 1C for 1 h. Embryos were then washed
in Rinse Buffer (2 mM MgCl2, 0.01% deoxycholic acid, 0.02% Igepal
CA-630, 100 mM sodium phosphate, pH 7.3) 3 times for 30 min
each at room temperature with slow rocking. The staining was
performed in Staining Solution (2 mM MgCl2, 0.01% deoxycholic
acid, 0.02% Igepal CA-630, 100 mM sodium phosphate, pH 7.3,
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and
1 mg/ml X-gal) overnight at room temperature and post-ﬁxed in
4% paraformaldehyde at 4 1C (Peng et al., 2008).
India ink injection
For gross examination of the development of pharyngeal arch
arteries, E10.5 and E12.5 embryos were injected with Pelican India
ink into the heart and ﬁxed overnight in 4% paraformaldehyde. After
a series of methanol/PBS dehydrations, the embryos were cleared in
2 volumes of benzyl benzoate and 1 volume benzyl alcohol. For great
vessel formation analysis, E18.5 embryo hearts were injected with
India ink and the images were taken right after injection.
NCC isolation and culture
Timed-pregnant female mice were euthanized and embryos were
harvested at E10.5. The ﬁrst and second pharyngeal arches were
dissected and incubated in 0.05% trypsin with 1 mM EDTA at 37 1C
for 2 min. The pharyngeal arches were pipetted up and down until
there were no large pieces of tissue visible. Fresh DMEM/F12 (GIBCO)
medium with 10% fetal bovine serum, 1 nonessential amino acids
(NEAA, GIBCO), Leukemia inhibitory factor (106 U/L), 100 IU/ml
penicillin and 100 mg/ml streptomycin were added to terminate
digestion. The isolated cells were then seeded in 6-well plates in
the same medium and incubated at 37 1C in a 5% CO2/95% air
incubator for 4 h. After 4 h, the culture medium was removed and
the attached cells were washed twice with DMEM/F12 before adding
fresh medium (John et al., 2011; Vallejo-Illarramendi et al., 2009).
Statistical analysis
Data are presented as mean7SEM. Means were compared by
2-tailed Student's t-test or 1-way ANOVA when comparing multi-
ple groups. Pr0.05 was considered statistically signiﬁcant.
Results
Inactivation of Cdc42 in NCCs induces craniofacial defects and thymus
aplasia
To investigate the role of Cdc42 in craniofacial and cardiovas-
cular development, we have generated NCC-speciﬁc Cdc42 knock-
out mice by crossing Cdc42/ﬂox mice with transgenic mice that
expressed Cre recombinase under the control of Wnt1 promoter
and regulatory sequences (Danielian et al., 1998). Screening of 266
postnatal 1 day (P1) pups showed that only 2% of Cdc42 NCC
knockout (CNKO) pups were born and perished shortly after birth.
However, 18 out of expected 20 live CNKO embryos were detected
at E14.5, and then died at various stages between E14.5 and P1
(Table 1). To determine whether Cdc42 had been deleted in NCCs,
we performed western blotting experiments on E10.5 pharyngeal
arches harvested from control (Cdc42ﬂox/ﬂox homozygous embryo)
and CNKO. Our results showed that the protein level of Cdc42 was
dramatically attenuated (around 80%) in CNKO pharyngeal arches
(Fig. S1A and B). Furthermore, we performed Cdc42 immunoﬂuor-
escence staining analysis on E10.5 CNKO and control embryos.
Cdc42 expression level was signiﬁcantly decreased in NCCs in
pharyngeal arch 1 at E10.5, comparing CNKO (Fig. S1D and F) to
control embryos (Fig. S1C and E), suggesting that Wnt1-cre can
efﬁciently inactivate Cdc42 in NCCs during development.
Whole-mount observation showed that the morphology of the
E10.5 control embryos (Fig. S2A) was indistinguishable from that
of CNKO embryos (Fig. S2B). However, CNKO embryos can be
recognized as early as E12.5 by observing hemorrhage in the
hindbrain and frontal cortex (Fig. 1B), which the littermate control
embryos did not exhibit (Fig. 1A). Compared with E14.5 control
embryos (Fig. 1C), CNKO embryos displayed an enlarged frontal
cortex (Fig. 1D). E16.5 CNKO embryos (Fig. 1F) showed short snouts
and encephalocele, but this phenotype was not present in the
control embryos (Fig. 1E). The most obvious facial alteration in
E18.5 CNKO embryos was a fully penetrant cleft lip (Fig. 1H and I),
which was not found in controls (Fig. 1G). Most CNKO embryos
exhibited a unilateral cleft lip (Fig. 1H), and around 10% of the
embryos presented with a bilateral cleft lip (Fig. 1I). An analysis of
E18.5 CNKO embryos also revealed a spectrum of craniofacial
developmental defects, including a shorter snout and cleft palate
(Fig. 1K and M), none of which were evident in controls (Fig. 1J and
L). In addition, we observed a well-developed thymus in E18.5
control embryos (Fig. 1N), but no or hypoplastic thymus was
detected in CNKO embryos (Fig. 1O). All of these data suggest that
Cdc42 in NCCs is important for craniofacial and thymus
development.
Cdc42 is required for craniofacial bone formation
To explore the role of Cdc42 in bony and cartilaginous devel-
opment of the head, we performed Alcian Blue and Alizarin Red
staining on E18.5 control (Fig. 2 A, C, and E) and CNKO embryos
(Fig. 2B, D, and F) to examine the 3-dimensional architecture of the
skeleton. Compared with the controls (Fig. 2A), the size and
morphology of NCC-derived bones, which include frontal bones,
incisive (premaxillary) bones, maxillary bones, and mandibles,
were dramatically ablated or completely absent in CNKO embryos
(Fig. 2B). The mandibles and incisive bones were shorter in CNKO
skulls and caused a reduction of the length of the snout (Fig. 2B).
A dorsal view of the CNKO skull displayed a deformity of the
frontal bone and the nasal bone that almost disappeared (Fig. 2D;
compare with Fig. 2C). A ventral view of control specimens
showed a fused nasal capsule premaxilla, and palatine (Fig. 2E).
Table 1
Genotypes of progeny from crosses to generate CNKO mice.
Genotype E10.5 E12.5 E14.5 E16.5 E18.5 P1 P21
ﬂox/þ 12 24 20 13 47 86 125
ﬂox/þ; Wnt1-Creþ 10 26 19 13 50 82 140
ﬂox/ﬂox (control) 10 25 21 15 42 94 147
ﬂox/ﬂox; Wnt1-Creþ (CNKO) 13 22 20 (2 demise) 11 (5 demise) 28 (10 demise) 4 0
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However, CNKO embryos displayed an unfused nasal capsule
premaxilla, and palatine (Fig. 2F). In addition, the middle region
of the hyoid bone was ossiﬁed in the control (Fig. 2G), but the
hyoid bone of CNKO embryos was malformed and no ossiﬁcation
was detected (Fig. 2H). The tympanic ring (Fig. 2I) and the
mandible (Fig. 2J) were similar in morphology in CNKO (right)
and control embryos (left), but were shorter and much smaller in
size. Quantitative analysis showed that the length of the tympanic
ring and the mandible were signiﬁcantly decreased in CNKO,
compared to the controls (Fig. 2K).
Deletion of Cdc42 in NCCs results in cardiovascular developmental
abnormalities
To address the role of Cdc42 in cardiovascular development,
India ink intracardiac injection assays were performed on E12.5
Fig. 1. Craniofacial and thymus defects in CNKO embryos. (A) through (F), Side view of E12.5 (A and B), E14.5 (C and D), and E16.5 (E and F) control (CO) (A, C, and E) and
CNKO embryos (B, D, and F). CNKO embryos displayed hemorrhage in the frontal cortex at E12.5 (B, yellow arrow), enlarged frontal cortex at E14.5 (D, yellow arrow), and
short snouts and encephalocele at E16.5 (F, yellow arrow). (G) through (I), Front view of E18.5 control (G) and CNKO embryos (H and I). CNKO embryos presented unilateral
(H, yellow arrow) or bilateral cleft lips (I, yellow arrow). (J) through (O), In comparison to E18.5 control embryos (J, L, and N), CNKO embryos exhibited short snout (K), cleft
palate (M, arrow head) and thymus aplasia (O). CO and CNKO stand for control and Cdc42 neural crest cell knockout embryos, respectively. Scale bars, 2 mm.
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and E18.5 embryos. At E12.5, there were no observable structural
differences in the fourth and sixth pharyngeal arch arteries between
the control (Fig. S3A) and CNKO embryos (Fig. S3B). At E18.5, the
pulmonary trunk arose from the base of the right ventricle and fully
separated with the right- and posteriorly-located ascending aorta in
the control embryos (Fig. 3A). However, CNKO embryos (16 out of 18)
showed persistent truncus arteriosus (Table 2), in which the ascend-
ing aorta and the pulmonary trunk failed to complete septation
(Fig. 3B). A hypoplastic pulmonary trunk (Fig. 3C) was also present in
CNKO embryos. In addition to outﬂow tract defects, the deletion of
Fig. 2. Craniofacial skeleton defects in E18.5 CNKO embryos. Lateral view of Alcian Blue (cartilage) and Alizarin Red (bone) stained control (CO) (A) and CNKO (B) craniofacial
skeleton. CNKO embryos showed overall impaired NCC-derived bone formation (F: frontal, PX: premaxilla, X: maxilla, ma: mandible). The mesoderm-derived parietal bone
(P) was mildly affected (B). Dorsal view (C and D) showed intact parietal bone (P) and malformed frontal bone (F) and nasal bone (N) in CNKO skull (D). Ventral view of
mouse skull (E and F). (*), (#) and (þ) in (F) indicate the unfused nasal capsule (NC), premaxilla (PX) and palatine (PL), respectively, compared with control (E). A ventral view
of the hyoid bone of control (G) and CNKO (H). I and J show hypoplasia of the tympanic ring (I, right side) and mandible bone (J, right side) from CNKO embryos. Quantative
analysis of the length of the tympanic ring and the mandible bone (K). Scale bars, 2 mm. *po0.05.
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Cdc42 in NCCs also induced abnormal aortic arch artery patterning,
including an interrupted aortic arch (Fig. 3D). We also observed
right-sided aortic arches (RSAA) (Fig. 3E) and aortic rings (AR)
(Fig. 3F) formed from the descending aorta and pulmonary trunk
in CNKO embryos. To examine the morphological changes in the
cardiac outﬂow tract, we utilized hematoxylin and eosin (H&E)
staining on the E18.5 control and CNKO embryos. Histological
analysis in control embryos showed that the aorta (AO) and the
pulmonary trunk (PT) artery were fully separated (Fig. 3G) and an
intact ventricular septum was developed (Fig. 3I), whereas CNKO
embryos displayed persistent truncus arteriosus (Fig. 3H) and were
always associated with ventricular septal defects (Fig. 3J and Table 2).
Impairment of NCC migration and actin remodeling in CNKO embryos
It was reported that interfering with cardiac NCC migration
caused defects in aortic arch artery patterning and outﬂow tract
septation (Hutson and Kirby, 2007; Stoller and Epstein, 2005).
To determine the cellular mechanisms of Cdc42 in cardiovascular
development, we have generated Wnt1-Cdc42-Rosa26 reporter
knockout mice and determined the effect of Cdc42 on NCC
migration. Whole-mount X-gal staining of E9.5 embryos showed
that there were two streams of migrating NCCs from the neural
tube toward pharyngeal arches 3, 4 and 6 in E9.5 control embryos
(Fig. 4A and C), but not in the CNKO (Fig. 4B and D). We observed
that the head and trunk region of E10.5 embryos was properly
populated by NCCs in both control (Fig. S4A) and CNKO embryos
(Fig. S4B). High magniﬁcation images showed that the inactivation
of Cdc42 did not affect NCC migration in the trunk region and that
NCC-derived cell-populated dorsal root ganglia and peripheral
nerves were comparable between control (Fig. S4C) and CNKO
(Fig. S4D). Inactivation of Cdc42 in NCCs did not signiﬁcantly affect
the NCC population in pharyngeal arches 1 and 2. However, we
noted that the LacZ staining in pharyngeal arches 3–6, especially in
pharyngeal arch 3, was attenuated (Fig. 4D, F, red arrow). Phar-
yngeal arch 3 is responsible for formation of the thymus and hyoid
bone, so the reduced NCC-population in pharyngeal 3 may be one
of possible reasons for the defective thymus and hyoid bone
formation. In addition, a subpopulation of NCCs migrated toward
the very end of the conotruncal cushions as two streams in control
embryos (Fig. 4E). However, the deletion of Cdc42 impaired NCC
migration to this region, as seen by LacZ-positive cells (Cdc42-null
NCCs) halting midway between the pharyngeal arch and the
conotruncal cushions (Fig. 4F). Quantitative analysis showed that
the relative distance of NCC migration was signiﬁcantly decreased
in CNKO embryos (Fig. 4I), suggesting that the impairment of NCC
migration is one of the potential mechanisms causing abnorma-
lities in great vessel formation in the CNKO embryos. In line with
Fig. 3. Cardiovascular development abnormalities in CNKO embryos. Examination of E18.5 control (A) and CNKO (B through F) aortic arch conﬁguration. CNKO embryos
exhibited malformation in aortic arches, including persistent truncus arteriosus (PTA) (B), hypoplastic pulmonary trunk (PT) (C) and interrupted aortic arch (IAA) (D). The
ascending aorta of CNKO embryos turned to the right (E) and formed a vascular ring (F). H&E staining showed PTA (H) and ventricular septum defects (VSD) (J) in E18.5 CNKO
embryonic hearts, but not in the control embryos (G, I). Scale bars, 1 mm.
Table 2
Summary of phenotypes in E18.5 Cdc42 mutant embryos.
Phenotype Number Penetrance (%)
Cleft lip 18/18 100
Cleft palate 18/18 100
Short snort 18/18 100
Encephalocele 15/18 83
Persistent truncus arteriosus 16/18 88
Interruption of aortic arch 3/18 17
Hypoplasia of Pulmonary trunk 4/18 22
Right aorta ring 2/18 11
Ventricular septum defects 4/4 100
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Fig. 4. Impairment of cardiac NCC migration in CNKO embryos. In vivo fate mapping studies showed two streams of migrating NCCs in the E9.5 control (A, C, yellow arrows),
but not in CNKO embryos (B, D). The red line indicates the distance of NCC migration to the conotruncal cushions in the E10.5 control (E) and CNKO embryos (F). E11.5 CNKO
embryos (H) displayed a shortened cardiac outﬂow tract, compared to the controls (G). Quantitative analysis of the NCC migration distance in E10.5 embryos (I) and the
length of cardiac outﬂow tract (OFT) in E11.5 embryos (J), *po0.05 vs. controls.
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Fig. 5. Decreased NCC numbers in the conotruncal cushions and defective actin remodeling in CNKO embryos. Eosin and LacZ staining analysis showed NCCs (blue colored
cells) in the conotruncal cushions of the controls (A), but far less NCCs in the CNKO embryos (B). (C) and (D) are the enlarged areas marked by the red circles in panels (A) and
(B), respectively. Phalloidin staining showed disorganized stress ﬁbers in CNKO embryos (F, H, yellow arrows). In contrast, NCCs formed stress ﬁbers, and their orientation
parallels the longitudinal cell axis in controls (E, G, yellow arrows). Nuclei stained with DAPI in control (I) and CNKO conotruncal cusions (J). Scale bars: (A and B) 1 mm;
(C through J) 0.25 mm.
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the results seen in E10.5 CNKO embryos, the deletion of Cdc42
impaired NCC migration in E11.5 CNKO outﬂow tract as well
(comparing Fig. 4H and G). We measured the length of the cardiac
outﬂow tract and found signiﬁcantly shortened cardiac outﬂow
tracts in the CNKO embryos (Fig. 4J). To further conﬁrm the
importance of Cdc42 in NCC migration, we performed histological
analysis by eosin staining. Consistent with the whole-mount
staining results, eosin and LacZ staining showed that the NCC
number (blue colored cells) in the conotruncal cushion was
signiﬁcantly decreased in CNKO embryos (Fig. 5B and D), com-
pared to the control embryos (Fig. 5A and C). NCC cytoskeleton
remodeling is essential for aortic and pulmonary trunk septation,
and the importance of Cdc42 in the regulation of cytoskeleton
remodeling in vitro is well appreciated (Cerione, 2004; Etienne-
Manneville, 2004; Vallejo-Illarramendi et al., 2009). To examine
the functions of Cdc42 in NCC cytoskeleton remodeling during
cardiac outﬂow tract formation, we carried out phalloidin (Fig. 5E,
F, G, and H) and DAPI nuclei counter staining (Fig. 5I and J) on E11.5
transverse sections of the conotruncal cushions. Phalloidin stain-
ing in control NCCs showed well-formed actin stress ﬁbers, and
their directions paralleled the longitudinal axis of each cell (Fig. 5E
and G). Interestingly, Cdc42-null NCCs exhibited dispersed,
shorter, and disoriented stress ﬁbers (Fig. 5F and H), indicating
that Cdc42 plays an indispensable role in actin remodeling in
Fig. 6. Ablation of Cdc42 in NCCs affects cell recruitment in the cardiac outﬂow tract. (A)–(D) Smooth muscle actin (SMA) and DAPI staining on E10.5 control embryos
showed SMA positive cells covering the whole outﬂow tract in the controls (A, B), but were absent in the distal part of outﬂow tract in CNKO embryos (marked by yellow
arrows) (C, D). (E)–(H) SM22alpha and DAPI staining on E11.5 control (E, F) and CNKO embryos (G, H). SM22alpha positive cell number was decreased in the CNKO outﬂow
tract (yellow arrows). Scale bars: (A through D) 0.1 mm; (E through F) 0.25 mm.
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NCCs. We also noted that the cell number in the conotruncal
cushions (marked by yellow circles) was signiﬁcantly decreased in
CNKO embryos (Fig. 5J), compared with the control embryos (Fig. 5I).
To determine the role of Cdc42 in NCC survival during devel-
opment, we performed terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) analysis on E10.5 control (Fig.
S5A and B) and CNKO (Fig. S5C and D) embryos. The outﬂow tract
region was visualized by troponin T (TnT) staining (a marker of
well-differentiated cardiomyocytes). We detected TUNEL positive
cells in the surrounding area of the outﬂow tract. However, we did
not ﬁnd any TUNEL positive cells in the outﬂow tract in either
control (Fig. S5B) or CNKO (Fig. S5D). Moreover, we examined the
role of Cdc42 on NCC proliferation. CNKO (Fig. S6B) and its control
embryos (Fig. S6A) with the Rosa26 reporter allele were sagittally
sectioned and stained with LacZ and phosphorylated histone H3.
The number of phosphorylated histone H3 positive cells in the
pharyngeal arches were comparable between control (Fig. S6C and
E) and CNKO (Fig. S6D and F) embryos. The results from TUNEL
and phosphorylated histone H3 staining assays suggest that the
inactivation of Cdc42 did not signiﬁcantly affect NCC-derived cell
survival and proliferation in the regions of the outﬂow tract and
pharyngeal arches at E10.5. Taken together, all of these data
indicate that the NCC migration defect is the major reason for
the decrease in NCC numbers in the conotruncal cushions of CNKO
embryos. The cardiac outﬂow tract conotruncal cushion is less
populated by NCC-derived cells in CNKO, so this may also affect
tissue remodeling and cause the aberrant outﬂow tract separation.
Ablation of Cdc42 in NCCs causes defects in cell recruitment and/or
differentiaton in the outﬂow tract
To determine the underlying mechanisms of the cardiac outﬂow
elongation defects in CNKO embryos, we harvested E10.5 control and
CNKO embryos and performed immunoﬂuorescence staining
analysis. Sagittal sections of embryos were stained with TnT (Fig.
S7A and C) and nuclei were counter-stained with DAPI (Fig. S7B and
D). Expression of TnT in control embryos was present along the
myocardial outﬂow tract and in the right and left ventricles (Fig. S7A
and B). Similarly, we detected the comparable TnT expression pattern
in CNKO embryos (Fig. S7C and D), suggesting that the inactivation of
Cdc42 in NCCs does not affect the addition of cardiomyocytes to the
cardiac outﬂow tract. Moreover, we performed vascular smooth
muscle actin (SMA) (a marker of vascular smooth muscle cells and
embryonic cardiomyocytes) (Fig. 6A and C) and DAPI (Fig. 6B and D)
staining on E10.5 CNKO and control embryos. SMA positive cells
covered the whole outﬂow tract in the controls (Fig. 6A and B).
However, SMA positive cells were absent in the distal portion of the
outﬂow tract in CNKO embryos (Fig. 6C and D). To conﬁrm the
importance of Cdc42 in smooth muscle cell recruitment and/or
differentiation in the outﬂow tract, we also stained SM22alpha
(Fig. 6E and G), a smooth muscle cell marker which expresses later
than that of SMA, and counter-stained the nuclei with DAPI (Fig. 6F
and H) on E11.5 embryos. Our data showed that SM22alpha positive
cells surrounded the outﬂow tract and populated conotruncal
cushions in the control (Fig. 6E and F) embryos. In contrast, the
SM22alpha positive cell number was signiﬁcantly decreased in the
outﬂow tract in CNKO (Fig. 6G and H). Unlike the expression pattern
of SMA-positive cells in E10.5 CNKO embryos, SM22alpha-positive
cells were present in E11.5 distal portion of the CNKO outﬂow tract.
Taken together, all of these data suggest that Cdc42 in NCCs is
required for smooth muscel cell recruitment and/or differentiation
during outﬂow tract formation.
Cdc42 is a critical effector in BMP2-induced NCC cytoskeleton
remodeling and migration
BMP2 plays an essential role in regulating NCC migration and
inhibition of Cdc42 functions impaires BMP2-induced F-actin-rich
Fig. 7. Effects of Cdc42 on BMP2-induced NCC migration. Immunoﬂuorescence staining of Sox-10 (A) and nuclei staining with DAPI (B) in cultured NCC-derived cells. A
merged picture is presented in panel (C). Yellow arrows indicate Sox10 positive cells. Cdc42ﬂox/ﬂox NCC-derived cells were infected with adenovirus-LacZ, Cre or Cre plus
hemagglutinin (HA)-tagged wild type Cdc42 for 72 h. The infected cells were then subjected to Boyden chamber assay in response to BMP2 stimulation (D). Aliquots of cell
lysates were analyzed by western blotting with antibodies for HA and vinculin (loading control) (E). *po0.05 for (D).
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spike-like ﬁlopodia formation (Gamell et al., 2008; Kanzler et al.,
2000). Strikingly, the inhibition of BMP2 receptors caused outﬂow
tract formation defects (Delot et al., 2003; Kaartinen et al., 2004;
Stottmann et al., 2004), which is similar to what we observed in
our CNKO embryos. To explore the role of Cdc42 and its signaling
partners in NCC polarization and directional migration, we isolated
primary NCCs from the pharyngeal arches of E10.5 Cdc42ﬂox/ﬂox
embryos using a trypsin digestion-based approach, as previously
described (John et al., 2011; Vallejo-Illarramendi et al., 2009).
Based on the data that we generated, the Sox10 (a general NCC
marker) positive cells were greater than 70% in cultured NCCs
(Fig. 7A–C). The cultured NCCs were inoculated with either
adenovirus (Ad)-Cre to delete Cdc42 or with Ad-LacZ as a control.
Next, we performed Boyden chamber assays on Cdc42-null and
control NCCs using BMP2 (3 nM) as a chemoattractant. Consistent
with our in vivo results, we found that the deletion of Cdc42
impaired NCC migration and that this effect can be rescued by
overexpression of hemagglutinin (HA) tagged wild type Cdc42
(Fig. 7D), indicating that Cdc42 plays an indispensable role in
BMP2-induced NCC migration. Western blotting analysis con-
ﬁrmed the deletion efﬁciency of Cdc42 (vinculin was blotted as a
loading control) (Fig. 7E). To further determine the underlying
mechanisms of Cdc42 in regulating NCC migration, we directly
isolated NCCs from E10.5 CNKO and control embryonic pharyngeal
arches. Consistent with a previous report, cytochalasin D treat-
ment disrupted the established stress ﬁbers in both control
(Fig. 8A) and CNKO NCCs (Fig. 8C). Microscopy examination
revealed that BMP2 stimulation induced F-actin protrusion for-
mation in control NCCs (Fig. 8B). However, the inactivation of
Cdc42 prevented the formation of ﬁlopodia-like structure in NCCs
isolated from CNKO embryos (Fig. 8D). We randomly examined
100 cells from multiple ﬁelds and divided the Sox10 positive cells
into three groups (non-ﬁlopodia-like protrusions, 1–5 protrusions
and more than 5 protrusions). The quantitative analysis results
showed that the inactivation of Cdc42 signiﬁcantly decreased
BMP2-induced ﬁlopodia formation in cells isolated from CNKO
embryos (Fig. 8E). It was reported that p38 is involved in BMP2-
induced cell migration (Gamell et al., 2011). To test whether p38 is a
downstream effector of Cdc42 in BMP2-stimulated NCC migration,
we performed western blots to determine the changes in p38
phosphorylation levels. We found that BMP2 stimulation increased
p38 phosphorylation in control NCCs and these effects were blunted
by the deletion of Cdc42 (Fig. 8F), suggesting that p38 is a potential
downstream effector of Cdc42 in regulating BMP2-induced cell
migration. Taken together, our data suggest that Cdc42 is an
important effector in BMP2-induced NCC cytoskeleton remodeling
and migration.
Discussion
NCCs originate from the dorsal neural tube and ventrolaterally
migrate to two transient embryonic structures called the fronto-
nasal prominence and pharyngeal arches, which ultimately
develop into craniofacial skeletons, as well as vasculature and
the conotruncal structures of the heart (Chai and Maxson, 2006;
Hutson and Kirby, 2007). In our studies, we found that the deletion
of Cdc42 in NCCs results in craniofacial defects with a short snout
and cleft palate. Also, the inactivation of Cdc42 in NCCs results in
cardiac outﬂow morphogenetic defects including PTA, pulmonary
trunk hypoplasia, and an interrupted aorta. Mechanism studies
indicate that the interference in actin cytoskeleton remodeling and
NCC migration towards the cardiac outﬂow tract are the reasons
for Cdc42 knockout-induced outﬂow tract defects.
The importance of Cdc42 in NCCs has been reported by Fuchs
et al. (2009). Both the current study and the article by Fuchs et al.
showed that the inactivation of Cdc42 in NCCs caused craniofacial
malformation, including a facial cleft. Using the genetic lineage
tracing technology (LacZ staining), Fuchs et al. found that the loss
of Cdc42 did not affect the NCCs’ ability to reach their initial target
structure, so Cdc42 plays a dispensable role in NCC migration. In
line with Fuchs’ report, we observed that NCCs populating their
peripheral destinations, including the head and trunk regions,
similar between the control and CNKO. However, one of the
discrepancies that we found, in terms of NCC migration, is that
the migration of a subgroup of NCC-derived cells from the
pharyngeal arch to the outﬂow tract was impaired in CNKO. The
reason only a subgroup of NCCs had migration interference, rather
than all NCCs, is that the different NCC populations may use
distinct signal transduction pathways for migration. Using a
cultured neural tube explant, Fuchs reported that Cdc42 was not
required for NCC emigration from the neural tube. However, we
found that Cdc42 is involved in BMP2-induced NCC migration and
cytoskeleton remodeling. The reasoning for this disagreement is
that we examined the responses of NCCs to BMP2 and Fuchs used
the full medium (containing FGF, EGF, etc.) as the migration
stimulator. Fuchs reported that Cdc42 is not required for NCC
proliferation at the early stage (E10.5), but plays an essential role
in the cell cycle progression after NCCs reach their destination
(E11.5). Consistently, our results also showed that the inactivation
of Cdc42 did not affect NCC proliferation at E10.5. We also noted
that the lethality stage of the Cdc42 knockout embryo is distinct.
Previous studies found that Cdc42 knockout embryos died before
E14.5 and our CNKO embryos can survive to E18.5. The reason
underlying this discrepancy remains unclear. It was documented
that the different genetic backgrounds may affect the phenotype in
the knockout mice (DiMichele et al., 2006; Peng et al., 2006), and
the genetic background of our mice is distinct from those of Fuchs.
Although we used a different ﬂox mouse line, our data do not
support the idea that the later lethality is due to insufﬁcient
deletion of Cdc42 in NCCs.
NCCs and the second heart ﬁeld (SHF)-derived cardiomyocytes
are two major cell types involved in the process of cardiac outﬂow
tract lengthening (Black, 2007; Goddeeris et al., 2007; Snider et al.,
2007). BMPs, which signal through heterodimeric receptors com-
posed of type I and II receptor serine/threonine kinases, play
essential roles in NCC migration and cardiac outﬂow tract devel-
opment (Stoller and Epstein, 2005). There are three known type I
receptors, including BMPR1A (ALK3), BMPR1B (ALK6) and ActRIA
(ALK2), two of which (ALK2 and ALK3) are involved in cardiac
outﬂow tract formation (Dudas et al., 2004; Kaartinen et al., 2004;
Kanzler et al., 2000; Stottmann et al., 2004). The deletion of ActRIA
(ALK2) in NCCs induced abnormal aortic arch artery patterning,
including PTA (Dudas et al., 2004; Kaartinen et al., 2004). Inactiva-
tion of BMPR1A (ALK3) in NCCs presented as a shortened cardiac
outﬂow tract with defective septation (Stottmann et al., 2004).
Moverover, overexpression of Xnoggin in premigratory/migratory
NCCs interfered with BMP2 functions, diminished migratory NCCs,
and resulted in abnormal skull skeleton morphogenesis (Kanzler
et al., 2000). In addition, BMPR2, one of the type II receptors of
BMPs, also participated in regulating cardiac outﬂow tract devel-
opment (Delot et al., 2003). Our data showed that the inactivation
of Cdc42 in NCCs impaired NCC migration and cardiac outﬂow
tract elongation, which was very similar to the phenotypes
observed in BMP signal transduction defective mice. Futhermore,
Cdc42 has been demonstrated to function as a downstream
effector of BMP2-induced cytoskeleton remodeling in vitro
(Gamell et al., 2008). BMP2 has multiple cellular functions,
including regulating NCC migration and survival (Correia et al.,
2007). Our data showed that Cdc42 is required for BMP2-induced
NCC cytoskeleton remodeling and migration. However, the inacti-
vation of Cdc42 in NCCs did not promote NCC apoptosis, indicating
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that Cdc42 is not involved in BMP2-induced NCC survival. Taken
together, these data indicate that the deletion of Cdc42 impaired
BMP-induced NCC cytoskeleton remodeling and cell migration,
and then caused the cardiovascular defects in our CNKO embryos.
We found that the deletion of Cdc42 in NCCs causes craniofacial
and cardiovascular defects. CrkL is located in the 22q11 zone and
encodes an adaptor protein that plays an essential role in integrin-
mediated cell migration (Feller, 2001). Previous studies have
shown that CrkL could activate Cdc42, and dominant negative
Cdc42 prevented CrkL-induced cytoskeleton remodeling (Oda
et al., 2001). Therefore, it is possible that, due to the deletion of
Cdc42, the CrkL-mediated signal transduction was impaired and
caused a craniofacial and cardiovascular defective phenotype in
our knockout mice. Another possiblility is that the Cdc42-related
craniofacial and cardiovascular phenotype may be due to inter-
ference with FAK-mediated signal transduction pathway. A recent
paper reported that a FAK deletion impaired craniofacial and
cardiovascular development (Vallejo-Illarramendi et al., 2009).
Our previous studies showed that FAK can activate Cdc42 through
Cool-1 (Feng et al., 2006). Therefore, it is possible that Cdc42 is one
of the downstream effectors of FAK in regulating actin cytoskele-
ton remodeling in NCCs and is involved in craniofacial and
cardiovascular structure formation.
Actin is the most abundant cytoskeleton protein in eukaryotic
cells and plays an important role in deﬁning cell shape and cell
migration. It is well recognized that Cdc42 is an important
regulator for the assembly and organization of the actin cytoske-
leton in various types of cells including ﬁbroblasts, neurons, and
Fig. 8. Cdc42 in BMP2-induced ﬁlopodia formation. NCCs were isolated from either E10.5 control (A and B) or CNKO (C and D) embryonic pharyngeal arches and cultured.
Serum starved cells were pretreated with cytochalasin D (2 μM) for 20 min and recovered with (B and D) or without (A and C) BMP2 (3 nM) stimulation for 1 h.
Immunoﬂuorescence staining were performed for Sox 10 (Green) and phalloidin (Red). Arrows indicate ﬁlopodia-like actin protrusions. (E) Quantitative analysis showed that
the deletion of Cdc42 impaired BMP2-induced ﬁlopodia formation. (F) Cell lysates were analyzed by western blotting with antibodies speciﬁc for phosphorylated p38
(p-p38), total p38 (T-p38), Cdc42, and vinculin (loading control). Scale bars, 25 μm.
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epithelial cells (Hall, 1998). The establishment of actin polymer-
ization is the driving force for cell migration and it requires that
active Cdc42 is recruited to the leading edge (Etienne-Manneville
and Hall, 2001). Inhibition of Cdc42 prevents directional move-
ment and reorientation of ﬁbroblast Golgi under cytokine stimula-
tion (Allen et al., 1998; Nobes and Hall, 1999). In our studies, we
found that the deletion of Cdc42 in NCCs impairs actin rearrange-
ment and prevents cell migration from the pharyngeal arches
toward the cardiac outﬂow tract. Moreover, the regulatory role of
Cdc42 on cytoskeleton remodeling and migration may occur
through many mechanisms. Based on the previous reports, active
Cdc42 could bring its downstream effectors (IRSp53, mDia2 and
N-WASP) together and contribute to the formation of the ﬁlopo-
dium, which contains parallel bundles of actin and is important for
cell migration (Ridley, 2011). In addition, the interaction between
Cdc42 and PAKs, a family of serine/threonine kinases, could
promote dissociation between PAK and cortactin. The released
cortactin relocalizes to ﬁlopodia and enhances actin polarization
(Vidal et al., 2002). Interestingly, we noted that the inactivation of
Cdc42 in NCCs only impaired NCC migration toward the cardiac
outﬂow tract, but had no noticeable effect on NCC migration
toward the head region and intersomite. The underlying mechan-
isms causing this discrepancy remain unclear and it is possible
that other Rho GTPases, like RhoF/Rif, may play a compensatory
role in NCC ﬁlopodia formation and migration, as reported before
(Pellegrin and Mellor, 2005).
In conclusion, our data demonstrate that Cdc42 plays an
essential role in NCCs during craniofacial and cardiovascular
development. The impairement of NCC migration is an underlying
mechanism of cardiovascular defects.
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